Susquehanna International Group
ARTL icon

Susquehanna International Group’s Artelo Biosciences ARTL Stock Holding History

Susquehanna International Group’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-126
Closed -$17.8K – 12603
2025
Q1 		$17.8K Buy
+126
New +$22.8K ﹤0.01% 12133
2022
Q3 		– Sell
-33
Closed -$25K – 13111
2022
Q2 		$25K Buy
33
+29
+725% +$25.7K ﹤0.01% 12295
2022
Q1 		$5K Sell
4
-3
-43% -$3.1K ﹤0.01% 12816
2021
Q4 		$8K Buy
+7
New +$12.4K ﹤0.01% 12951

Other funds holding ARTL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Susquehanna International Group's ARTL Position: Q2 2025 in Review

Susquehanna International Group sold out of Artelo Biosciences (ARTL) in Q2 2025, closing a stake of 126 shares — an estimated $17.8K sold.

Susquehanna International Group first reported a position in ARTL in Q4 2021 and held it in 4 quarters. The position peaked at $25K in Q2 2022. 3 funds tracked by Wall St. Rank hold ARTL as of Q2 2025.

  • Susquehanna International Group reported no remaining Artelo Biosciences position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 126 Artelo Biosciences shares in Q2 2025, an estimated $17.8K.
  • Susquehanna International Group first reported a position in Artelo Biosciences in Q4 2021 and held it in 4 quarters.
  • Susquehanna International Group's Artelo Biosciences position peaked at $25K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Artelo Biosciences as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.